March 25, 2013
Have you assessed the impact of OTC regulation on your business?
An interesting analysis by the law firm Jones Day on the potential impact of the U.S. Dodd-Frank Act over at Lexology. As the article puts it, you should first review your OTC derivatives transactions and the identity and regulatory status of your counterparties to determine your exposure to various requirements. This won't be an easy task due to incomplete rules and the ambiguities arising under newly issued rules that have not been tested in the market. Whatever the size of your exposure to Dodd-Frank and global OTC regulations may be though, knowing your business first will help you plan on the appropriate next steps and avoid unnecessary delays. Maria L
Popular
Most Viewed
Articles
Jun. 20, 2022
Regulatory change and data fragmentation are key challenges for 85% of firms
Jun. 13, 2022
Driving competitive advantage from FX TCA to LPA
Jun. 09, 2022
Three leading banks join CLSNet
Jun. 08, 2022
FMSB – Financial markets misconduct in global capital markets
May. 31, 2022